TPD52L2 and adrenal cortex carcinoma: In addition, TPD52L2 expression was higher in relatively worse tumor stages in adrenocortical carcinoma (ACC), BLCA, BRCA, LIHC, and LUAD, while it was lower in relatively worse tumor stages in KICH (Figures 2O–T).